AstraZeneca Plc (AZN)

40.12
0.61 1.50
NYSE : Health Technology
Prev Close 40.73
Open 40.52
Day Low/High 40.06 / 40.59
52 Wk Low/High 35.30 / 43.30
Volume 3.71M
Avg Volume 3.31M
Exchange NYSE
Shares Outstanding 2.62B
Market Cap 104.84B
EPS 0.80
P/E Ratio 18.26
Div & Yield 1.37 (3.40%)
Institutional Selling, Europe's Economy, Nvidia Earnings Preview: Market Recon

Institutional Selling, Europe's Economy, Nvidia Earnings Preview: Market Recon

What trader has never both fallen in love with Nvidia, only to eventually feel the scorn of an angry lover's tortured vengeance?

The New Small Biotechs Heating Up the Medical Cannabis Space

The New Small Biotechs Heating Up the Medical Cannabis Space

These companies are working to plant their flag in a new landscape.

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

One of pharma's biggest CEO's talks M&A action on the exchange.

Buy Struggling Progenics and Dynavax Here

Buy Struggling Progenics and Dynavax Here

Both biotech stocks are at or near 52-week lows, but don't deserve to be.

Novice Trade: EWU United Kingdom ETF

Novice Trade: EWU United Kingdom ETF

This at-the-money, long put shooter is a high risk trade, so use discretionary capital.

Novice Trade: EWU ETF

Novice Trade: EWU ETF

This portfolio cannot be trusted to be diversified enough.

The Race to Cure Alzheimer's is On: These Are the Forerunners

The Race to Cure Alzheimer's is On: These Are the Forerunners

Top pharmaceutical companies are paving the way to a cure for Alzheimer's, a degenerative disease that is affecting millions around the world.

2 Small Biotechs I Like in the Second Half

2 Small Biotechs I Like in the Second Half

Adamis Pharmaceuticals and Pieris Pharmaceuticals are names to watch.

Latest Reasons to Avoid Alzheimer's Plays

Latest Reasons to Avoid Alzheimer's Plays

Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.

Biotech Bargains: Two Cheap Small-Cap Stocks in an Exciting Sector

Biotech Bargains: Two Cheap Small-Cap Stocks in an Exciting Sector

I continue to see these names as bargains in the biotech and biopharma space.

Small Cap Biotech Bargains

Small Cap Biotech Bargains

Here are 2 small caps I continue to see as bargains in this space.

4 Great Dividend Stocks That Always Remember to Say 'Thank You': Market Recon

4 Great Dividend Stocks That Always Remember to Say 'Thank You': Market Recon

These dividend payers compete in businesses that I'm interested in and believe in -- and they pay me to own the shares.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

3 Potential Biotech Buyout Targets in the Second Quarter

3 Potential Biotech Buyout Targets in the Second Quarter

Novartis' deal for AveXis has ignited a rally in other gene-therapy concerns.

Possible Biotech Takeout Plays

Possible Biotech Takeout Plays

A look at possible second-quarter M&A activity in the biotech sector.

It's Been a Fine Earnings Season, but Here Come the Retailers: Market Recon

It's Been a Fine Earnings Season, but Here Come the Retailers: Market Recon

Surviving the age of Amazon is all there is to retailers' earnings.

Geron Shares Rise on Fast Track Designation -- Biotech Movers

Geron Shares Rise on Fast Track Designation -- Biotech Movers

The FDA granted fast track designation to imetelstat as a potential treatment for adults with with transfusion-dependent anemia.

3 Small Biotech Stocks Insiders Are Buying

3 Small Biotech Stocks Insiders Are Buying

Verastem Inc., Pieris Pharmaceuticals and Intra-Cellular Therapies all have promising products.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

This week's bullish and bearish reversal patterns.

AstraZeneca Shares Sink on Lackluster Mystic Drug Results

AstraZeneca Shares Sink on Lackluster Mystic Drug Results

AstraZeneca shares are tanking.

China Was Right to Walk Away From Failed U.S. Trade Talks

China Was Right to Walk Away From Failed U.S. Trade Talks

The collapse of the Sino-American session on tariffs and access translates into market action for investors, and inaction on improved trade.

These 3 Small Biotechs Have a Healthy Shot

These 3 Small Biotechs Have a Healthy Shot

Several firms hiked price targets on Portola into the $70s this week.

Give These 3 Small Biotechs a Shot

Give These 3 Small Biotechs a Shot

Several firms hiked price targets on Portola into the $70s this week.

Wake Up Wall Street: U.K. Prime Minister Theresa May Takes on Tech Companies

Wake Up Wall Street: U.K. Prime Minister Theresa May Takes on Tech Companies

U.K. Prime Minister Theresa May says technology companies have to do more to combat hate speech.

Closing Bell: GlobalStar Soars on Deal Considerations; Retail Sinks Wall Street Again

Closing Bell: GlobalStar Soars on Deal Considerations; Retail Sinks Wall Street Again

Stocks end the session mixed after Nordstrom and J.C. Penney become the latest retail names to report on a weak quarter.

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.

Keep Trading AstraZeneca From the Long Side

Keep Trading AstraZeneca From the Long Side

The stock is headed toward a bullish golden cross.